These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36678931)

  • 1. Design, Development, and Optimisation of Smart Linker Chemistry for Targeted Colonic Delivery-In Vitro Evaluation.
    Abd-Ellah HS; Mudududdla R; Carter GP; Baell JB
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies toward Organic Carbon Monoxide Prodrugs.
    Ji X; Wang B
    Acc Chem Res; 2018 Jun; 51(6):1377-1385. PubMed ID: 29762011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and ex vivo evaluation of colon-specific azo based prodrugs of anticancer agents.
    Sharma R; Rawal RK; Gaba T; Singla N; Malhotra M; Matharoo S; Bhardwaj TR
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5332-8. PubMed ID: 23968824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs.
    Reddy SM; Sinha VR; Reddy DS
    Drugs Today (Barc); 1999 Jul; 35(7):537-80. PubMed ID: 12973398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon Cancer and Specific Ways to Deliver Drugs to the Large Intestine.
    Derakhshankhah H; Izadi Z; Alaei L; Lotfabadi A; Saboury AA; Dinarvand R; Divsalar A; Seyedarabi A; Barzegari E; Evini M
    Anticancer Agents Med Chem; 2017; 17(10):1317-1327. PubMed ID: 28270073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation into drug release from colon-specific azoreductase-activated steroid prodrugs using in-vitro models.
    Ruiz JF; Kedziora K; Windle H; Kelleher DP; Gilmer JF
    J Pharm Pharmacol; 2011 Jun; 63(6):806-16. PubMed ID: 21585379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis and Studies on Novel Polymeric Prodrugs of Erlotinib for Colon Drug Delivery.
    Kumar S; Sharma B; Bhardwaj TR; Singh RK
    Anticancer Agents Med Chem; 2021; 21(3):383-392. PubMed ID: 32781967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment.
    Edupuganti VVSR; Tyndall JDATDA; Gamble AB
    Recent Pat Anticancer Drug Discov; 2021; 16(4):479-497. PubMed ID: 33966624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target-specific drug release to the colon.
    Jain SK; Jain A
    Expert Opin Drug Deliv; 2008 May; 5(5):483-98. PubMed ID: 18491977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colon targeted drug delivery systems--an overview.
    Kumar P; Mishra B
    Curr Drug Deliv; 2008 Jul; 5(3):186-98. PubMed ID: 18673262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1
    Monastyrskyi A; Brockmeyer F; LaCrue AN; Zhao Y; Maher SP; Maignan JR; Padin-Irizarry V; Sakhno YI; Parvatkar PT; Asakawa AH; Huang L; Casandra D; Mashkouri S; Kyle DE; Manetsch R
    J Med Chem; 2021 May; 64(10):6581-6595. PubMed ID: 33979164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azo chemistry and its potential for colonic delivery.
    Jain A; Gupta Y; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2006; 23(5):349-400. PubMed ID: 17425512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.
    Sawarkar SP; Deshpande SG; Bajaj AN; Nikam VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1445-54. PubMed ID: 26017284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon.
    Pandey S; Swamy SMV; Gupta A; Koli A; Patel S; Maulvi F; Vyas B
    J Microencapsul; 2018 May; 35(3):259-271. PubMed ID: 29659317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Kim HH; Kong HS; Kim YM
    Arch Pharm Res; 2003 Apr; 26(4):264-9. PubMed ID: 12735682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic drug delivery: prodrug approach.
    Sinha VR; Kumria R
    Pharm Res; 2001 May; 18(5):557-64. PubMed ID: 11465408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems.
    Zou M; Okamoto H; Cheng G; Hao X; Sun J; Cui F; Danjo K
    Eur J Pharm Biopharm; 2005 Jan; 59(1):155-60. PubMed ID: 15567313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on stercuia gum formulations in the form of osmotic core tablet for colon-specific drug delivery of azathioprine.
    Nath B; Nath LK
    PDA J Pharm Sci Technol; 2013; 67(2):172-84. PubMed ID: 23569078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and development of novel azo prodrugs using various permutations and combinations of 5- and 4-aminosalicylic acids for inflammatory bowel disease: a colon-targeted approach.
    Suneela D; Gaurav V; Himanshu R
    Inflamm Allergy Drug Targets; 2013 Oct; 12(5):328-40. PubMed ID: 24001333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.